JSAM
MRNA icon

J. Safra Asset Management’s Moderna MRNA Stock Holding History

J. Safra Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Sell
328
-458
-58% -$23.7K ﹤0.01% 313
2026
Q1 		$39.9K Buy
786
+20
+3% +$933 ﹤0.01% 272
2025
Q4 		$22.6K Buy
+766
New +$20.8K ﹤0.01% 317
2023
Q1 		– Sell
-2
Closed – – 119
2022
Q4 		$0 Buy
+2
New +$327 ﹤0.01% 85

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

J. Safra Asset Management's MRNA Position: Q2 2026 in Review

J. Safra Asset Management reduced its Moderna (MRNA) stake by 58% in Q2 2026, selling an estimated $23.7K and leaving 328 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

J. Safra Asset Management first reported a position in MRNA in Q4 2022 and has held it in 4 quarters since. The position peaked at $39.9K in Q1 2026. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • J. Safra Asset Management held 328 shares of Moderna worth $23K as of Q2 2026.
  • J. Safra Asset Management sold 458 Moderna shares in Q2 2026, an estimated $23.7K.
  • Moderna made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #313 holding.
  • J. Safra Asset Management first reported a position in Moderna in Q4 2022 and has held it in 4 quarters since.
  • J. Safra Asset Management's Moderna position peaked at $39.9K in Q1 2026.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.